Cardinal Health (NYSE:CAH) Sets New 1-Year High – Should You Buy?

Cardinal Health, Inc. (NYSE:CAH)’s share price reached a new 52-week high on Tuesday . The stock traded as high as $205.48 and last traded at $205.26, with a volume of 2111062 shares changing hands. The stock had previously closed at $203.67.

Analyst Upgrades and Downgrades

A number of analysts have issued reports on the company. Jefferies Financial Group set a $220.00 target price on Cardinal Health and gave the company a “buy” rating in a research report on Monday, November 3rd. Evercore ISI lifted their price objective on Cardinal Health from $190.00 to $220.00 and gave the company an “outperform” rating in a research note on Friday, October 31st. Leerink Partners increased their target price on Cardinal Health from $187.00 to $211.00 in a research note on Friday, October 31st. Wells Fargo & Company raised their target price on Cardinal Health from $185.00 to $221.00 and gave the company an “overweight” rating in a report on Wednesday, November 5th. Finally, Mizuho boosted their price target on shares of Cardinal Health from $170.00 to $210.00 and gave the stock an “outperform” rating in a research note on Monday, November 3rd. Twelve research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $205.00.

Cardinal Health Trading Up 0.8%

The company has a market cap of $48.77 billion, a PE ratio of 31.82, a P/E/G ratio of 1.39 and a beta of 0.72. The company has a fifty day simple moving average of $161.15 and a two-hundred day simple moving average of $157.36.

Cardinal Health (NYSE:CAH) last announced its quarterly earnings data on Thursday, October 30th. The company reported $2.55 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.22 by $0.33. Cardinal Health had a negative return on equity of 74.45% and a net margin of 0.70%.The business had revenue of $64.01 billion during the quarter, compared to analysts’ expectations of $59.41 billion. During the same quarter last year, the business posted $1.88 EPS. The business’s quarterly revenue was up 22.4% compared to the same quarter last year. Cardinal Health has set its FY 2026 guidance at 9.650-9.850 EPS. On average, research analysts anticipate that Cardinal Health, Inc. will post 7.95 EPS for the current fiscal year.

Cardinal Health Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, January 15th. Shareholders of record on Friday, January 2nd will be given a $0.5107 dividend. The ex-dividend date of this dividend is Friday, January 2nd. This represents a $2.04 dividend on an annualized basis and a dividend yield of 1.0%. Cardinal Health’s dividend payout ratio is currently 30.77%.

Insider Buying and Selling at Cardinal Health

In other news, insider Michelle D. Greene sold 13,500 shares of Cardinal Health stock in a transaction on Tuesday, August 19th. The shares were sold at an average price of $148.82, for a total transaction of $2,009,070.00. Following the completion of the sale, the insider directly owned 14,976 shares of the company’s stock, valued at approximately $2,228,728.32. The trade was a 47.41% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Jessica L. Mayer sold 38,078 shares of the stock in a transaction on Tuesday, August 19th. The shares were sold at an average price of $148.82, for a total value of $5,666,767.96. Following the completion of the transaction, the insider directly owned 48,457 shares in the company, valued at $7,211,370.74. This trade represents a 44.00% decrease in their position. The SEC filing for this sale provides additional information. In the last quarter, insiders sold 271,676 shares of company stock worth $40,489,525. 0.12% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Cardinal Health

Several institutional investors have recently added to or reduced their stakes in the business. SJS Investment Consulting Inc. lifted its position in shares of Cardinal Health by 1,363.6% during the 3rd quarter. SJS Investment Consulting Inc. now owns 161 shares of the company’s stock worth $25,000 after buying an additional 150 shares during the last quarter. Greykasell Wealth Strategies Inc. acquired a new stake in Cardinal Health during the 1st quarter worth $26,000. Jones Financial Companies Lllp lifted its position in Cardinal Health by 198.3% in the first quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company’s stock valued at $27,000 after acquiring an additional 14,034 shares during the last quarter. Atlantic Edge Private Wealth Management LLC boosted its stake in Cardinal Health by 75.0% in the second quarter. Atlantic Edge Private Wealth Management LLC now owns 175 shares of the company’s stock valued at $29,000 after acquiring an additional 75 shares in the last quarter. Finally, American Capital Advisory LLC grew its holdings in shares of Cardinal Health by 5,200.0% during the third quarter. American Capital Advisory LLC now owns 212 shares of the company’s stock worth $33,000 after purchasing an additional 208 shares during the last quarter. Hedge funds and other institutional investors own 87.17% of the company’s stock.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.